Citigroup’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.31M Sell
392,268
-204,504
-34% -$2.45M ﹤0.01% 2096
2026
Q1
$3.57M Buy
596,772
+90,721
+18% +$683K ﹤0.01% 2233
2025
Q4
$3.63M Buy
506,051
+285,564
+130% +$2.26M ﹤0.01% 2240
2025
Q3
$2.35M Sell
220,487
-27,479
-11% -$270K ﹤0.01% 2546
2025
Q2
$2.4M Sell
247,966
-4,969
-2% -$51.2K ﹤0.01% 2476
2025
Q1
$3.77M Sell
252,935
-92,801
-27% -$1.43M ﹤0.01% 2176
2024
Q4
$5.16M Buy
345,736
+165,468
+92% +$2.7M ﹤0.01% 1924
2024
Q3
$3.45M Buy
180,268
+18,216
+11% +$378K ﹤0.01% 2169
2024
Q2
$3.35M Sell
162,052
-72,183
-31% -$1.43M ﹤0.01% 1931
2024
Q1
$4.4M Sell
234,235
-1,178
-0.5% -$20.2K ﹤0.01% 1801
2023
Q4
$3.39M Sell
235,413
-237,218
-50% -$3.23M ﹤0.01% 1854
2023
Q3
$8.2M Buy
472,631
+161,249
+52% +$3.36M 0.01% 1197
2023
Q2
$6.48M Buy
311,382
+127,703
+70% +$2.78M ﹤0.01% 1343
2023
Q1
$4.32M Buy
183,679
+34,818
+23% +$935K ﹤0.01% 1572
2022
Q4
$4.16M Sell
148,861
-7,851
-5% -$201K ﹤0.01% 1560
2022
Q3
$3.67M Buy
156,712
+68,147
+77% +$2.06M ﹤0.01% 1727
2022
Q2
$2.99M Sell
88,565
-25,756
-23% -$902K ﹤0.01% 1822
2022
Q1
$3.99M Sell
114,321
-25,942
-18% -$887K ﹤0.01% 1808
2021
Q4
$4.27M Sell
140,263
-53,996
-28% -$1.76M ﹤0.01% 1954
2021
Q3
$6.37M Sell
194,259
-407,191
-68% -$13M ﹤0.01% 1657
2021
Q2
$18.2M Buy
+601,450
New +$19.8M 0.01% 1053

Other funds holding OGN

Citigroup's OGN Position: Q2 2026 in Review

Citigroup reduced its Organon & Co (OGN) stake by 34% in Q2 2026, selling an estimated $2.45M and leaving 392,268 shares worth $5.31M. The position accounts for ﹤0.01% of the portfolio, ranked #2096.

Citigroup first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $18.2M in Q2 2021. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Citigroup held 392,268 shares of Organon & Co worth $5.31M as of Q2 2026.
  • Citigroup sold 204,504 Organon & Co shares in Q2 2026, an estimated $2.45M.
  • Organon & Co made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #2096 holding.
  • Citigroup first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • Citigroup's Organon & Co position peaked at $18.2M in Q2 2021.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.